Method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -14814.80% · OPTIONAL
· Electromedical & Electrotherapeutic Apparatus
RESEARCH SNAPSHOTNexalin Technology, Inc.'s latest supported as-filed period reports revenue of $12,161, 82.8% below the comparable as-filed period; gross margin moved 551 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -14814.80% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -82.77% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 1919.76% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 73.16% · CORE
Level · gp.fundamentals.operating_margin
Raw value -18479.69% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 4641.72% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 35.0%; Inventory / revenue moved 167471 bp higher.
2 evidence-backed componentsOperating income changed -38.6% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
NXL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001829126-26-009659SEC ↗8-KAug 27, 2026Period Aug 26, 20260001829126-26-009387SEC ↗8-KAug 21, 2026Period Aug 21, 20260001829126-26-009226SEC ↗8-KAug 20, 2026Period Aug 19, 20260001829126-26-009173SEC ↗8-KAug 17, 2026Period Aug 14, 20260001829126-26-008934SEC ↗10-QAug 12, 2026Period Jun 30, 20260001829126-26-008709SEC ↗8-KAug 11, 2026Period Aug 11, 20260001829126-26-008621SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Dec 19, 2025Filed Dec 23, 2025 | White MarkCEO | Grant Or AwardDirect | 1,000,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 3358.17% · OPTIONAL
Research & development changed +150.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -41.6% from the comparable as-filed period.
Gross margin changed +551 basis points from the comparable as-filed period.
Operating margin changed -1618347 basis points from the comparable as-filed period.
Revenue changed -82.8% from the comparable as-filed period.
Cash & equivalents changed +133.0% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001829126-26-008047